You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

Top Ten "Must Attend" Breakout Sessions at the 2011 BIO International Convention

John Sterling’s picks:
TOP TEN “MUST ATTEND” BREAKOUT SESSIONS

74 - Getting Approval for Drugs in an Ever-Increasing Risk-Averse World (Track: Achieving Regulatory Approval and Compliance)
Monday, June 27
2:00 pm - 3:15 pm

  • Give insight on the changing regulatory environment and critical success factors for new applications.
  • Describe the challenges of a filing process from the company’s and regulator’s point of view.
  • Learn how to get a cell therapy product evaluated as a drug.

77 - Talking About Your Product in the New Age: Social Media and the Internet (Track: Achieving Regulatory Approval and Compliance) 
Tuesday, June 28
3:45 pm - 5:00 pm

  • Understand current regulatory standards and policies related to dissemination of information outside of labeling.
  • Understand current venues for disseminating product information on the Internet and through social media.
  • Understand potential liability, and identify measures to avoid it.

90 - Rediscovering the Promise of Biomarkers (Track: Biomarkers) 
Tuesday, June 28
8:30 am - 9:45 am

  • Learn about new models for international PPPs to reduce risk and cost for biomarker research.
  • Understand the regulatory challenges facing the biomarkers qualification and validation.
  • Explore how to work internationally to leverage resources for biomarker research.

198 - Crossing the Financing Gap? Alternative Strategies for Funding Biomedical Technologies for the Clinic (Track: Finance) 
Monday, June 27
2:00 pm - 3:15 pm

  • Describe innovative strategies that leverage alternative sources of capital to enable development.
  • Discuss current financing for clinically related biotechnologies, including nontraditional sources.
  • Discover nondilutive NIH funding opportunities and resources that support early development.

98 - Personalized Medicine and Companion Diagnostics: The Changing Biopharma Industry Landscape (Track: Diagnostics and Personalized Medicine) 
Thursday, June 30
8:30 am - 9:45 am

  • Develop an understanding of the personalized medicine landscape.
  • Interact with thought leaders in the industry.
  • Give audience the opportunity to follow up for potential collaborative initiatives.

174 - The Effect of a More Risk Averse Environment on Licensing Deals (Track: Business Development) 
Monday, June 27
2:00 pm - 3:15 pm

  • Describe the current environment within licensing biopharma companies with regard to risk for in-licensed programs.
  • Indicate specific risk management strategies and their implications.
  • Give advice from licensees on how best to strategize with a licensing partner.

188 - The Changing BD Environment: Overcoming Our Past to Succeed in the Future (Track: Business Development) 
Tuesday, June 28
2:00 pm - 3:30 pm

  • Explain the dynamics (type, economics, timing, roles) driving biotech/pharma collaborations.
  • Conceptualize novel approaches to biotech and pharma collaborations.
  • Identify key deal showstoppers from either a historical or novel transaction approach.

110 - Improving Innovation Through the Use of Social Networks (Track: Global Innovations & Markets) 
Thursday, June 30, 2011
8:30 am - 9:45 am

  • Participants will appreciate how to manage risk of engaging on social networks.
  • Show how open networks may help solve big problems in innovation.
  • Explain strategic considerations necessary for social networking initiatives.

126 - The Vaccine Business Opportunity — Breakthrough Technologies for Preventing and Treating Disease (Track: Innovations in Vaccines) 
Monday, June 27
3:45 pm - 5:00 pm

  • Identifying challenges and opportunities for vaccines in preventing infection and treating cancer.
  • Give the perpsective of big biotech and pharma in this field—both established and new players.
  • Describe the investor perspective on vaccines and which approaches are most likely to be funded.

141 - Safer, Faster, Cheaper: Changing Process Paradigms, Platforms and Products in Biomanufacturing (Track: Manufacturing of Biologics and Drugs)
Thursday, June 30
8:30 am - 9:45 am

  • Describe the paradigm shift from handcrafted to mature process technologies in biomanufacturing.
  • Describe how the FDA’s initiatives have sped the adoption of process methods since 1997.
  • Demonstrate how the process controls enable faster, cheaper and safer biologics.